Table 5.
Univariate Analysis of Risk Factors for the Recurrence Free Survival and Progression Free Survival in Patients with Bladder Cancer
CIS, carcinoma in situ; PUNLMP, papillary urothelial neoplasm of low malignant potential; AR, androgen receptor; ERβ, estrogen receptor beta.